インディアナ州における小細胞肺がんの臨床試験
インディアナ州内の拠点で、小細胞肺がんに関する12件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Fort Wayne Medical Oncology And Hematology /ID# 277336, Fort Wayne
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07155174A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Franciscan St. Francis Health /ID# 279788, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Indiana University (IU) Health - Multi-D Oncology Clinic, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06095505Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Roudebush VA Medical Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/14更新 · NCT05889546A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office, Fort Wayne
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583A Study of LY4175408 in Participants With Advanced Cancer
- Community Health Network, Indianapolis
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07153055MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/29更新 · NCT05903092Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/08更新 · NCT04919382Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/11更新 · NCT06681220ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。